Evaluation of the effect of chamomile(matricaria chamomilla) extract on severity of anxiety before root canal therapy

Evaluation of the effect of chamomile(matricaria chamomilla) extract on severity of anxiety before root canal therapy in anxious patient

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210516051320N1

Enrollment

Registered

2021-08-11

Start date

2021-06-22

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety before root canal treatment. Anxiety disorder, unspecified

Interventions

Intervention 1: Intervention group: In the intervention group, according to the instruction of the manufacturer. The patient consumes 30 oral drops of chamomile extract produced by Sina Faravar Pharma

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A patient volunteering for endodontic treatment who scores more than 11 and less than 19 on the Anxiety Scale Patient consent The patient has a healthy mental state and the ability to fill out a questionnaire

Exclusion criteria

Exclusion criteria: The patient has used sedatives The patient has a history of allergy to chamomile The patient has asthma The patient takes warfarin

Design outcomes

Primary

Measure	Time frame
Anxiety score in MDAS questionnaire. Timepoint: Anxiety scores are measured in two stages before the intervention and one hour after. Method of measurement: Modified Dental Anxiety Questionnaire (MDAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Torabizadeh

Esfahan University of Medical Sciences

torabizadeh@dnt.mui.ac.ir+98 31 3628 8528

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026